Aakaar Medical Technologies Limited, a leading name in the medical equipment and healthcare technology sector, has officially announced the release of the audio and video recordings of its Investor Meet held on October 9, 2025, at 4:00 PM (IST). This update has been made pursuant to Regulation 30(6), Schedule III, Part A, Para A (15), and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, commonly referred to as the SEBI Listing Regulations.

The announcement was made by Mr. Anoopkumar Pillai, the Company Secretary and Compliance Officer of Aakaar Medical Technologies Limited. In his filing to the National Stock Exchange of India (NSE), he confirmed that the recordings are now publicly available on the company’s official website. Investors and stakeholders can access them directly through the following link:
https://aakaarmedical.in/disclosures-as-per-regulation-46-of-the-sebi-lodr-regulations/#tab_audiorecordings,-video-recordings,-and-transcripts.

The purpose of this disclosure is to maintain transparency and provide timely information to all shareholders, analysts, and members of the public who follow the company’s financial developments. This step aligns with SEBI’s ongoing emphasis on fair disclosure practices, which are designed to protect investors and uphold integrity in the capital markets.

Importance of SEBI Regulation 30 Compliance

Under SEBI Regulation 30, listed companies are required to make timely disclosures of all material events and developments that may influence investor decisions. This includes audio or video recordings, transcripts of analyst calls, and investor interactions. By publishing these materials online, Aakaar Medical demonstrates its commitment to corporate governance and fair investor relations.

The audio and video recordings provide stakeholders with insights into the company’s operational performance, strategic direction, and management outlook. Such transparency helps investors assess the company’s business health and strategic priorities.

Details of the Investor Meet

The Investor Meet was organized to update shareholders about the latest business developments, financial performance, and growth strategies of Aakaar Medical Technologies Limited. During the session, the management team addressed key areas such as:

• Innovation in medical technology and upcoming product lines.

• Market expansion and new regional partnerships.

• Financial results and performance outlook for FY2025–26.

• Sustainability and R&D initiatives in the healthcare device segment.

Investors were given a platform to raise queries, which were answered by senior executives, ensuring interactive engagement and clarity on business operations.

Digital Transparency and Corporate Governance

The company’s decision to make these recordings publicly available is a significant move toward digital transparency. In recent years, SEBI has encouraged companies to use digital disclosure mechanisms to improve accessibility for investors and analysts.

Aakaar Medical Technologies has consistently adhered to SEBI norms by:

• Timely uploading of disclosures under Regulation 46 on its website.

• Regular updates to financial statements, policies, and governance reports.

• Making all investor communication materials publicly accessible.

Such practices not only strengthen investor confidence but also reinforce the company’s reputation as a responsible and transparent listed entity.

About Aakaar Medical Technologies Limited

Aakaar Medical Technologies Limited (formerly Aakaar Medical Technologies Pvt. Ltd.), based in Andheri (East), Mumbai, is a healthcare technology company engaged in the design, development, and supply of advanced medical devices and systems. The company operates with a strong focus on innovation, regulatory compliance, and customer trust.

Registered under CIN No.: L74900MH2013PLC244717, the company maintains its principal office at A-801, Heritage Plaza, Teli Gali Cross Road, Andheri (East), Mumbai – 400069. The firm is known for offering innovative medical technologies that meet both domestic and international healthcare standards.

Investor Communication Commitment

The latest disclosure reflects Aakaar Medical’s continuous efforts to maintain open communication channels with its stakeholders. By providing full access to the recordings and transcripts, the company ensures that all shareholders receive equal access to vital information.

Transparency in communication helps in:

• Building trust among investors.

• Promoting accurate market perception.

• Ensuring regulatory compliance as per SEBI’s LODR requirements.

Conclusion

In conclusion, the publication of the Investor Meet audio and video recordings on the company’s website marks another milestone in Aakaar Medical’s journey toward full corporate transparency. The company’s actions are in strict compliance with SEBI Regulation 30 and underscore its dedication to fair disclosure and ethical corporate governance.

As the healthcare industry continues to evolve with rapid technological advancements, Aakaar Medical Technologies remains focused on innovation, compliance, and stakeholder engagement. This proactive communication approach ensures that investors stay well-informed and confident in the company’s direction.

The firm’s compliance-driven strategy and emphasis on transparency reaffirm its position as a responsible corporate citizen in India’s growing medical technology landscape.

For further updates, investors are encouraged to visit the company’s official website at www.aakaarmedical.in, where all regulatory filings, reports, and meeting updates are regularly published under the Investors and Disclosures section.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.